Introdução: Em diversos países, inclusive no Brasil, a fortificação de alimentos com ácido fólico (AF) foi adotada como política pública de prevenção e combate à deficiência nutricional da vitamina, motivados principalmente pela redução da incidência dos defeitos do tubo neural. No período pós-fortificação observa-se tanto a evolução positiva do consumo e nível sérico da vitamina quanto a diminuição da concentração plasmática de homocisteína, e ainda, o aumento do ácido fólico não metabolizado na maioria desses países. Não se conhece ainda os efeitos biológicos do AFNM, no entanto, considera-se que o AFNM pode ser um fator relevante nas questões de segurança associadas com alto consumo de AF. Objetivo: Avaliar o consumo dietético e nível de folato, homocisteína e ácido fólico não metabolizado após a fortificação mandatória de alimentos com ácido fólico, e a interação com os polimorfismos envolvidos no metabolismo do folato e homocisteína. Metodologia: Os dados foram oriundos do estudo transversal de base populacional ISA Capital 2008 conduzido em uma amostra representativa de residentes do município de São Paulo, de ambos os sexos, e com idade acima de 14 anos. Coletou-se recordatórios alimentares de 24 horas e amostra de sangue em jejum de 12 horas para análises bioquímicas e moleculares. As análises estatísticas foram realizadas no programa STATA®, versão 13.0, com nível de significância de 5 por cento . Resultados: O estudo foi conduzido em 750 indivíduos, sendo 53,1 por cento mulheres e média de idade 40,7 (IC95 por cento 38,8-42,5) anos. A média de consumo e nível de folato foi de 375,8 (IC95 por cento 363,0-388,6) mcg/dia e 13 (IC95 por cento 12,0-13,9) ng/ml, respectivamente. Apenas 1,76 por cento da população apresentou deficiência de folato (<3ng/ml). Foi 5 detectado AFNM em 79,8 por cento da população com média plasmática de 2,4 (IC95 por cento 2,1-2,7) ng/ml. No modelo linear generalizado para previsão de AFNM, nível de folato (p<0,001), idade (p<0,001), tabagismo (p=0,002), raça (p<0,001) e concentrações de B6 (p<0,001), além disso, a interação de homozigotos e heterozigotos para a deleção de pares de base da DHFR e nível de folato (p=0,003) foram efeitos significantes. Tem-se um aumento relativo esperado de 3 por cento no AFNM se aumentarmos em 1 ng/ml o nível de folato médio, considerando fixas as demais variáveis do modelo. Conclusão: Nota-se baixa prevalência da deficiência da vitamina e alta prevalência dos níveis detectáveis de AFNM na população decorrente do aumento do nível de folato. Todavia, apesar do aparente sucesso da fortificação de alimentos com ácido fólico, a comunidade científica não é unânime na aprovação de políticas de fortificação mandatória e do uso indiscriminado de suplementos. Recomenda-se um monitoramento constante para evitar que a população seja exposta a altas doses da vitamina, e consequentemente, efeitos adversos à saúde. / Introduction: Food fortification is an important strategy in public health policy for controlling micronutrient malnutrition, and a major contributory factor in the eradication of micronutrients deficiencies. Motivated by the reduction in the occurrence of neural tube defects, countries worldwide, including Brazil, adopted food fortification with folic acid (FA). Folic acid fortification has increased dietary intakes of folic acid and folate status, but it is also associated with the presence of circulating FA. Although the metabolism and biological effects of circulating of folic acid are not well known, it may be a contributing factor in safety concerns associated with high oral doses of folic acid. Objective: To assess the folate intake and status, homocysteine and circulating FA after mandatory fortification with folic acid, and interaction with polymorphisms involved in 1-carbon metabolism. Material and Methods: Data were from 750 individuals aged > 14 years old who participated of a cross-sectional population-based survey in Sao Paulo City-Brazil. Fasting blood samples and information about food intake based on two measures of 24 hour food recall were collected. All analyses were carried out using STATA (version 13.0) and p-value <.05 was considered to be statistically significant in all tests. Results: Results were from 750 individuals. Women accounted for 53.1 per cent of the population and average age was 40.7 (IC95 per cent 38.8-42.5) years. The overall mean folate intake and folate concentration were 375.8 (95 per cent CI: 363.0-388.6) mcg/day of DFE and 13 (95 per cent CI: 12-14) ng/mL, respectively. Only 1.76 per cent of 7 population had folate deficiency (<3 ng/mL). Circulating FA was detected in 79.8 per cent of the population with a mean concentration of 2.4 (95 per cent CI: 2.1-2.7) pmol/ml. Effects of total folate concentration (p<0.001), age (p<0.001), current smoker (p=0.002), race (p<0.000) and vitamin B6 (p<0.001) as well as interaction between folate concentration and 19-base pair deletion polymorphism in DHFR (p=0.003) were found in the model to predict the circulating FA. An increase of one ng/mL in folate concentrate was associated with increased of 3 per cent in circulating FA. Conclusions: There is low prevalence of folate deficiency and high prevalence of detectable levels of circulating FA the population. The fortification effectively increased folate status and folic acid intake, and had a notable influence on rankings of food contributors of folate intake. Although the success of folic acid fortification was observed in many countries, the scientific community is not unanimous in approval of mandatory fortification policies and the indiscriminate use of supplements. The monitoring is recommended to guarantee the safety of exposure to folic acid, and avoiding adverse health effects.

Anemia and micronutrient deficiencies in infancy are common in low-income settings. These are partly due to maternal malnutrition and may impair child health and development. We studied the impact of maternal food and micronutrient supplementation, duration of exclusive breastfeeding (EBF), growth and infection on infant anemia and micronutrient status. In the MINIMat trial in Matlab, Bangladesh, pregnant women were randomized to Early or Usual promotion of enrolment in a food supplementation program and to one of three daily micronutrient supplements. Capsules containing 400µg folic acid and (a) 30 mg iron (Fe30Fol), (b) 60 mg iron (Fe60Fol), (c) 30 mg iron and other micronutrients (MMS) were provided from week 14 of gestation. Capsule intake was assessed with the eDEM device recording supplement container openings. Blood samples (n=2377) from women at week 14 and 30 were analyzed for hemoglobin (Hb). Duration of EBF and infant morbidity was based on monthly maternal recalls. Infants were weighed and measured monthly. Blood samples (n=1066) from 6-months-old infants were analyzed for Hb and plasma ferritin, zinc, retinol, vitamin B12 and folate. In women, Hb increase per capsule reached a plateau at 60 Fe60Fol capsules, indicating that nine weeks of daily supplementation produced maximum Hb response. Anemia was common (36%) at capsule intakes &gt;60 indicating other causes of anemia than iron deficiency. In infants, vitamin B12 deficiency prevalence was lower in the MMS (26.1%) than in the Fe30Fol group (36.5%), (p=0.003) and zinc deficiency prevalence was lower in the Usual than in the Early group. There were no other differential effects of food or micronutrient supplementation on infant anemia or micronutrient status. Infants exclusively breast-fed for 4-6 months had a higher mean plasma zinc concentration (9.9±2.3 µmol/L) than infants exclusively breast-fed for &lt;4 months (9.5±2.0 µmol/L), (p&lt; 0.01). No other differences in anemia, iron or zinc status were observed between EBF categories. Infection, low birth weight and iron deficiency were independent risk factors for infant anemia. Regardless of studied interventions, prevalence of anemia (43%), deficiency of zinc (56%), vitamin B12, vitamin A (19%) and iron (22%) in infancy was high and further preventive strategies are needed. / MINIMat

Neural tube defects (NTDs) are serious birth defects that affect 3,000 pregnancies in the United States annually. All women of childbearing age are recommended to consume 400 micrograms of folic acid daily for the prevention of NTDs. Women aged 18 to 24 years have multiple risk factors for having an NTD-affected pregnancy and should be targeted by efforts to promote folic acid consumption. Survey data capturing folic acid awareness, knowledge, and supplementation behavior of women aged 18 to 24 years who are not contemplating pregnancy were examined to identify the relationship of folic acid awareness and knowledge to daily supplementation with folic acid in an effort to predict the effectiveness of education-only interventions. Results of the study suggested that awareness and knowledge was not consistently related to daily supplementation. An evaluation of qualitative data using the Health Belief Model offers explanations for the findings and recommendations for targeting these at-risk women.

Folate sind als Überträger von C1-Fragmenten verschiedener Oxidationsstufen direkt an der Nukleinsäuresynthese beteiligt und spielen somit eine entscheidende Rolle im Zellstoffwechsel. So kann ein suboptimaler Folatstatus zur Ausprägung einer klinischen Symptomatik führen, die sich primär in Zellen mit hoher Teilungsrate manifestiert. Dabei gilt die megaloblastäre Anämie als Leitsymptom für einen akuten Folatmangel. Herausragende Bedeutung besitzen Folate in der Schwangerschaft, wo ihnen bei der Entwicklung des fetalen Nervensystems eine besondere Rolle zukommt. Bei einem zu niedrigen Serumfolatspiegel der Mutter steigt das Risiko für embryonale Missbildungen wie Neuralrohrdefekte stark an. Die weitere medizinische Relevanz der Folate steht momentan im Fokus der Forschung, wie z. B. der protektive Effekt in Bezug auf bestimmte Krebsformen, die Risikoreduktion für verschiedene kardiovaskuläre Erkrankungen sowie Zusammenhänge zwischen dem Folatstatus und neurologischen Störungen (Alzheimer, Depressionen). Allerdings kann Folat als essentielles Vitamin von Säugetieren nicht selbst synthetisiert werden, sondern muss aus externen Quellen über den Verdauungstrakt aufgenommen werden. Die Resorption aus dem Darm erfolgt nach aktuellem Kenntnisstand insbesondere über den Reduced Folate Carrier (RFC, SLC19A1) und den Proton-Coupled Folate Transporter (PCFT, SLC46A1). Trotz der Existenz dieser spezifischen Transporter ist der Folatmangel des Menschen der häufigste Vitaminmangel in Mitteleuropa. Er lässt sich durch eine ausschließlich ernährungsphysiologische Problematik nur unzureichend erklären. Interessanterweise besitzen sowohl das PCFT-Gen als auch das RFC-Gen in ihrer Promoterregion verschiedene Regulationselemente, unter anderem auch funktionell aktive DREs (Dioxin Response Element), die als Bindungsstelle für einen ligandenaktivierten Transkriptionsfaktor, den nukleären Arylhydrocarbon-Rezeptor (AhR), dienen. DREs wurden bisher hauptsächlich bei fremdstoffmetabolisierenden Enzymen wie z. B. Cytochrom P450-Isoenzymen gefunden und vermitteln bekanntermaßen die toxischen und karzinogenen Effekte von AhR-Liganden. Von besonderem Interesse sind in diesem Zusammenhang ubiquitär verbreitete Umweltkontaminanten wie die polyzyklischen und die halogenierten aromatischen Kohlenwasserstoffe (PAK, HAK), da sie in der Umwelt sehr persistent sind und sich dadurch in der Lebensmittelkette anreichern. Infolgedessen wurde im Rahmen dieser Studie der mögliche Einfluss von AhR-Liganden wie TCDD (2,3,7,8-tetrachlordibenzo-p-dioxin) und B[a]P (Benzo[a]pyren) auf die carriervermittelte intestinale Folatresorption beim Menschen untersucht sowie die Regulation der Transportproteine RFC und PCFT auf transkriptioneller Ebene experimentell überprüft. Als adäquates in vitro Modell diente dabei die humane Kolonzelllinie LS180, für die zunächst eine Charakterisierung erfolgte. Mittels RT-PCR wurde der Nachweis erbracht, dass alle am Folattransport beteiligten Import-und Exportcarrier auf mRNA-Ebene exprimiert werden. Für die Transportproteine RFC und PCFT erfolgte über den Western Blot auch der Nachweis auf Proteinebene. Die Funktionalität der AhR-Signalkaskade, die über methylcholanthrenartige Induktoren wie TCDD zur Induktion von Cytochrom P450 führt, konnte im Folgenden mittels Ethoxyresorufin-O-deethylase-Assay (EROD) überprüft werden. Es zeigte sich nach Induktion mit TCDD (0,01 - 10 nM) oder B[a]P (0,01 - 1 μM) über 12 – 96 h ein hochsignifikanter, dosis- und zeitabhängiger Effekt auf die Cyp1A1 vermittelte Enzymaktivität der Ethoxyresorufin-O-deethylase in den LS180-Zellen. Dabei konnten ligandenabhängige Unterschiede im Induktionsmuster ermittelt werden. Im Anschluss wurde im intestinalen Zellmodell die initiale konzentrations- und zeitabhängige Folataufnahme bei pH 5.5 über funktionelle Aufnahmeversuche mit Tritium-markierter Folsäure untersucht und charakterisiert. Sie stellte sich als aktiver, sättigbarer Prozess dar, wobei in den unbehandelten LS180-Zellen ca. eine Verdreifachung der intrazellulären Radioaktivität über einen Zeitraum von 2,5 min beobachtet werden konnte. Als kinetische Parameter wurden ein Km-Wert von 27,91 μM sowie ein Vmax-Wert von 281,2 pmol/min berechnet. Nachfolgende Untersuchungen mit den spezifischen Inhibitoren Raltitrexed (RTX) und Pemetrexed (PMX) konnten zeigen, dass sowohl PCFT als auch RFC an der funktionellen Folsäureaufnahme bei einem pH-Wert von 5.5 in dem gewählten Versuchsaufbau beteiligt sind. Der RFC scheint jedoch einen etwas höheren Anteil an der Gesamtaufnahme zu haben als der PCFT. In LS180-Zellen, die vorher mit den Modellsubstanzen TCDD (1 bzw. 10 nM) oder B[a]P (0,1 bzw. 1 μM) über 24 - 120 h inkubiert wurden, konnte eine zeit- und dosisabhängige, statistisch signifikante Reduktion der carriervermittelten Folatresorption beobachtet werden, wobei die maximale Verminderung der Aufnahmerate ca. 75 % betrug. Da sich dieser Effekt durch die AhR-Antagonisten Salicylamid (SAL) und CH-223191 (CH) dosisabhängig umkehren ließ, erfolgt die Regulation vermutlich über den AhR-Signalweg. Um den Mechanismus der Regulation zu klären, wurde mit Hilfe der quantitativen qRT-PCR unter Verwendung von TaqMan-Sonden die Genexpression von RFC und PCFT nach Vorbehandlung mit 1 - 10 nM TCDD oder 0,1 – 1 μM B[a]P über 12 - 120 h untersucht. Analog zu den Aufnahmeversuchen konnte hier eine zeit- und dosisabhängige Reduktion beider Transporter auf transkriptioneller Ebene beobachtet werden. Auch führte eine Vorbehandlung mit CH und SAL wiederum zu einer Umkehr des Effektes, wobei CH wahrscheinlich einen ligandenselektiven AhR-Antagonisten darstellt. Zusammenfassend konnte durch die vorliegende Arbeit nachgewiesen werden, dass Cytochrom P450-Induktoren über die AhR-Signalkaskade die carriervermittelte Folatresorption in humanen Kolonzellen herabregulieren. Es erscheint anhand der gewonnen Erkenntnisse möglich, dass die Folathomoöstase durch verschiedene Umweltkontaminanten wie z. B. TCDD negativ beeinflusst werden kann und als Folge daraus auch eventuell der Folatmangel der Bevölkerung in Industrienationen zumindest teilweise erklärbar wird. Es ist darüber hinaus denkbar, dass auch andere Fremdstoffe die Folataufnahme beeinflussen, da große planare Strukturen häufig über den AhR-Weg wirken. Weiterführende Studien sind notwendig, um das Verständnis für den Einfluss von Umweltkontaminanten auf die intestinale Folataufnahme zu verbessern.

Neural tube defects (NTD) result from the failure of the neural tube to close properly very early in gestation. A child born with an NTD may experience an early death or life-long disability. In the 1990s, the critical role of folic acid in the prevention of NTDs was confirmed and as a strategy to increase blood folate concentrations of women of childbearing age, folic acid fortification programs were mandated in Canada and the US. However, this change impacted the entire population not just women of childbearing age and not everyone may benefit from the increased folate intake. The objective of this research was to investigate the impact of higher intakes of folates on the mortality rates of children with acute lymphoblastic leukemia (ALL) and the risk of colorectal cancer (CRC) in adult populations. To address the impact in children with ALL, a comparison of the mortality rates between the pre- and post-fortification time periods in Ontario was performed using data from the Pediatric Oncology Group of Ontario. A second comparison between the mortality rates in these children in non-folic acid fortifying countries and the US was also completed. These analyses suggest that folic acid fortification is not negatively impacting mortality. With respect to CRC, one systematic review and two meta-analyses were conducted investigating folate intake and the risk of CRC or adenoma recurrence. The first analysis, in observational studies, compared high versus low folate intake and the risk of CRC. The second examined folate intake within the various polymorphisms of the methylene tetrahydrofolate reductase enzyme. The final study examined the impact of supplementation of 1 milligram or more per day of folic acid and the risk of colorectal adenoma recurrence in those adults with a history of colorectal adenomas. The findings from the completed observational studies suggest that there is an associated risk reduction in colorectal cancer from the intake of higher levels of folates. The investigations into the impact of the folic acid fortification program suggest that the program is not associated with having a negative impact on mortality of children with ALL or on the risk of colorectal cancer.

Neural tube defects (NTD) result from the failure of the neural tube to close properly very early in gestation. A child born with an NTD may experience an early death or life-long disability. In the 1990s, the critical role of folic acid in the prevention of NTDs was confirmed and as a strategy to increase blood folate concentrations of women of childbearing age, folic acid fortification programs were mandated in Canada and the US. However, this change impacted the entire population not just women of childbearing age and not everyone may benefit from the increased folate intake. The objective of this research was to investigate the impact of higher intakes of folates on the mortality rates of children with acute lymphoblastic leukemia (ALL) and the risk of colorectal cancer (CRC) in adult populations. To address the impact in children with ALL, a comparison of the mortality rates between the pre- and post-fortification time periods in Ontario was performed using data from the Pediatric Oncology Group of Ontario. A second comparison between the mortality rates in these children in non-folic acid fortifying countries and the US was also completed. These analyses suggest that folic acid fortification is not negatively impacting mortality. With respect to CRC, one systematic review and two meta-analyses were conducted investigating folate intake and the risk of CRC or adenoma recurrence. The first analysis, in observational studies, compared high versus low folate intake and the risk of CRC. The second examined folate intake within the various polymorphisms of the methylene tetrahydrofolate reductase enzyme. The final study examined the impact of supplementation of 1 milligram or more per day of folic acid and the risk of colorectal adenoma recurrence in those adults with a history of colorectal adenomas. The findings from the completed observational studies suggest that there is an associated risk reduction in colorectal cancer from the intake of higher levels of folates. The investigations into the impact of the folic acid fortification program suggest that the program is not associated with having a negative impact on mortality of children with ALL or on the risk of colorectal cancer.

Diss. (sammanfattning) Linköping : Univ., 2004. / Härtill 4 uppsatser.

Thesis (Mnutr)--University of Stellenbosch, 2003. / ENGLISH ABSTRACT: Pregnancy and growth have been found to have a detrimental effect on the micronutrient status of adolescent girls. Dietary studies in adolescents have shown serious shortfalls in their dietary iron and folate intake. The competition for nutrients between the fetus and a pregnant adolescent may carry the risk of complications such as intrauterine growth retardation, pre-eclampsia, both maternal and fetal intrapartum mortality, the increased risk of birth injuries and low birth weight. The aim of the study was to assess the nutritional status of rural black, pregnant teenagers attending the antenatal clinic at Siloam Hospital in the Limpopo Province, with special emphasis on iron and folic acid intake, and evaluation of the newborn babies in terms of weight status and neural tube defects. The nutritional status was determined in 40 pregnant and 40 non-pregnant adolescent girls. The pregnant girls were selected during their first visit to the antenatal clinic, and the non-pregnant girls were selected from nearby schools. The demographic and dietary history questionnaires were used to collect information from the subjects. The dietary intake of the subjects was collected by the completion of a pre-tested quantified food frequency questionnaire. The anthropometric questionnaire was used to get information from the pregnant adolescents and the control group. The infant anthropometric measurements questionnaire provided information on the infant and the outcome of birth. Blood was collected from the pregnant adolescent girls and the control subjects. Anaemia was observed in 57.5% of the pregnant and 27.5% of the non-pregnant adolescents (haemoglobin <Il g/dl and <12 g/dl, respectively). The prevalence of low serum ferritin « 12 ug/L) and low transferrin saturation « 16%) was high in both the pregnant (30% and 60% respectively) and the non-pregnant adolescents (17% and 72.5% respectively). Iron deficiency was observed in 45% of the pregnant girls and 35% of the control subjects. The prevalence of iron deficiency anaemia in the pregnant girls (30%) and the control subjects (22.5%) was high. Low red blood cell folate in pregnant and non-pregnant girls was uncommon. Low serum vitamin BI2 was common in most of the pregnant girls. Analysis of the quantitative food frequency questionnaire (QFFQ) that was completed for 80 of the pregnant and non-pregnant girls showed that 55% had low dietary iron intakes «67% of the RDA) (p = 0.7307). Forty-five percent of the pregnant girls reported taking iron supplements. The QFFQ showed 20% of pregnant girls with low intake of folate (p = 0.0577). Forty-five percent of pregnant girls also reported taking folate supplements. Anthropometric measurements of pregnant girls and their dietary intake could not be correlated to the birth outcome. The social profile of the subjects did not seem to influence their iron and folate status and the outcome of pregnancy. The findings in this study showed that pregnant adolescents appeared to be similar to the non-pregnant adolescent girls socio-economically, anthropometric and nutritionally. We recommend that educational programmes targeted at adolescents and teenagers in the Siloam area should reach girls that could potentially fall pregnant. An educational programme must include: reproductive needs (avoidance of sex or safe sex); nutritional needs, especially targeted at improving nutritional status to meet future reproductive needs; early booking at the antenatal clinic and effective supplementation during pregnancy. The need to improve the dietary and nutrient intake of the adolescent girls should be addressed within the current framework of the Integrated Nutrition Programme (!NP). A food fortification programme with essential micronutrients such as iron, folic acid, zinc and Vitamin A to improve the micronutrient status should be promoted among the adolescent girls. / AFRIKAANSE OPSOMMING: Daar is bevind dat swangerskap en groei 'n nadelige effek het op die mikronutriëntstatus van vroulike adolessente. Dieetstudies in adolessente het ernstige tekortkominge in dieetyster- en folaatinnames getoon. Die kompetisie vir nutriente tussen die fetus en die swanger adolessent kan verantwoordelik wees vir komplikasies soos intra-uterine groeivertraging, preeklampsie, verhoogde mortaliteit van beide moeder en baba tydens kraam, 'n verhoogde risiko vir geboortebeserings en lae geboortegewig. Die doel van die studie was om die effek van voedingstatus by swart, swanger tieners by die voorgeboortekliniek in Siloam Hospital in die Limpopo-provinsie te bepaal, met spesifieke verwysing na die yster- en foliensuurinname, asook die evaluering van die pasgebore babas in terme van gewig en neurale buis defekte. Die voedingstatus van 40 swanger en 40 nie-swanger adolessente meisies IS bepaal. Die swanger meisies is ewekansig geselekteer gedurende die eerste besoek aan die voorgeboortekliniek , en die nie-swanger meisies is geselekteer by nabygeleë skole. Die demografiese en dieetgeskiedenisvraelyste is gebruik om inligting van die proefpersone in te samel. Voorafgetoetste gekwantifiseerde voedselfrekwensie vraelyste is gebruik om die voedselinname van proefpersone te bepaal. Antropometriese vraelyste is gebruik om antropometriese inligting van die swanger adolessente en die kontrole groep. Die antropometriese vraelys vir babas is gebruik om inligting ten opsigte van die baba aan te teken asook die verloop van die swangerskap. Bloedmonsters is van die swanger tieners en die kontrole groep ingesamel. Anemie is waargeneem by 57.5% van die swanger en 27.5% van die nie-swanger adolessente (hemoglobien <Il g/dl en <12 g/dl onderskeidelik). Die voorkoms van lae serum ferritien « 12 ugIL) en lae transferrienversadiging « 16%) was hoog by beide die swanger (30% en 60%) en die nie-swanger adolessente (17.5% en 72.5% onderskeidelik). Ystergebrek is in 45% van die swanger meisies en in 35% van die kontrole groep waargeneem. Die voorkoms van ystergebrekanemie in die swanger meisies (30%) en die kontrole groep (22.5%) was hoog. Lae rooibloedselfolaat by swanger en nie-swanger meisies is nie algemeen waargeneem nie. Lae serum vitamien B12 was algemeen by die meeste swanger meisies. Ontleding van die gekwantifiseerde voedselfrekwensievraelys (KVFV) wat vir 80 van die swanger en nie-swanger meisies voltooi is, het getoon dat 55% 'n lae dieetysterinname gehad het «67% van die ADT) (p=0.7307). Vyf-en- veertig persent van die swanger meisies het bevestig dat hulle ystersupplemente gebruik het. Die gekwantifiseerde voedselfrekwensievraelys (KVFV) het getoon dat 20% van die swanger meisies 'n lae folaatinname het (0.0577). Vyf-en-veertig persent van die swanger meisies het ook genoem dat hulle folaatsupplemente gebruik het. Die antropometriese metings van swanger meisies en dieetinname kon nie gekorreleer word met die verloop van die geboorte nie. Dit blyk dat die sosiale profiel van die meisies nie 'n effek op die yster- en folaatstatus en op die verloop van swangerskap gehad het nie. Die bevindinge van hierdie studie toon dat swanger en nie-swanger adolessente meisies sosio-ekonomies, antropometries en nutrisioneel dieselfde voorkom. Dit word aanbeveel dat voorligtingsprogramme vir adolessente en tieners in die Siloam-area meisies moet bereik wat moontlik swanger sal word. 'n Voorligtingprogram moet die volgende insluit: reproduktiewe behoeftes (vermyding van seks of veilige seks); voedingbehoeftes, veral geteiken om voedingstatus te verbeter om ten einde toekomstige voorplantingsbehoeftes te vervul; vroeë besoeke aan die voorgeboortekliniek en effektiewe supplementering gedurende swangerskap. Die behoefte om die dieet en nutriëntinname van adolessente meisies te verbeter moet binne die huidige raamwerk van die Geintegreerde Voedingsprogram aangespreek word. 'n Voedselfortfiseringsprogram met essensiële mikronutriënte soos yster, foliensuur, sink en vitamien A om die mikronutriëntstatus van adolessente meisies te verbeter, moet bevorder word.

Objetivo: Verificar se há diferença entre o consumo habitual de folato entre mães de crianças com Síndrome de Down e mães de crianças sem malformações. Métodos: Foi realizado um estudo de caso-controle, com um total de 100 mães das quais 50, incluídas no grupo caso, apresentavam filhos com Síndrome de Down e 50, consideradas grupo controle,tinham filhos sem malformações congênitas. Aplicou-se um questionário de consumo habitual de alimentos contendo questões relativas à classificação sócio-econômica e ao consumo de alimentos-fonte e alimentos fortificados com esta vitamina. Todas participantes assinaram o Termo de Consentimento Livre e Esclarecido. Resultados: Entre as variáveis analisadas, somente a quantidade de ácido fólico consumida habitualmente e a idade no momento do nascimento do filho, diferiram-se significantemente entre os grupos. Mães caso consumiram em média 359,1 μg/dia (dp ± 91,9) de folato, enquanto as mães do grupo controle, 425,5 μg/dia (dp± 104,3), (p=0,001). A idade que tiveram seus filhos foi no grupo caso 27, 5 anos (dp± 4,8) de e no grupo controle de 25,4 (dp ±5,3), (p=0,042). Somente 3,4% das entrevistadas relataram uso de ácido fólico ou polivitamínicos de forma periconcepcional ou em algum momento da gestação. Conclusões: Embora pelo presente estudo tenha havido diferença significativa entre o consumo de folato no grupo caso e no controle é importante que não se descarte possíveis fatores bioquímicos envolvidos e aqui não avaliados. / Objective: Check if exists difference between the usual consumption of folate in mothers of children with Down Syndrome and in mothers of children without congenital abnormalities. Methods: A case-control study was accomplished, with a sample of 100 mothers from which, 50 had children with Down Syndrome and 50, considered group control, children without congenital abnormalities. A questionnaire of quantitative frequency was applied containing questions related to the socioeconomic class and the food-source consumption, and foods fortified with folic acid. All participants signed the Informed Consent Form. Results: Among the variables in analysis, only the daily amount of folic acid consumed and the age that the mothers had their babies were significant different between the two groups. Mothers of children with Down Syndrome consumed 359,1 μg/day (dp ± 91,9) of folate, while the mothers of control group consumed, 425,5 μg/day (dp± 104,3), (p=0,001). The age that they had their babies were in group case 27, 5 years (dp± 4,8) and in the control group, 25,4 (dp ±5,3), (p=0,042). Only 3,4% of the interviewee related use of folic acid or others vitamines before or during the pregnancy. Conclusion: Although in the present study has been a significant difference between the consumption of folate in the case group and in the control, is important not to discard possible biochemical factors involved and here not evaluated.

Realizou-se um estudo descritivo conduzido no Hospital de Clínicas de Porto Alegre, no período de outubro de 2001 a outubro de 2002, com pacientes HIV positivos e anêmicos. Objetivo: avaliar a associação entre anemia e o perfil nutricional em uma amostra de pacientes HIV+ . Métodos: Foram incluídos 34 pacientes maiores de 18 anos, sendo todos pacientes diagnosticados com anemia. Foram analisados exames laboratoriais, avaliação da ingestão alimentar (recordatório alimentar de 24h), freqüência alimentar e coleta dos parâmetros antropométricos dos pacientes. Resultados: O recordatório alimentar de 24 horas demonstrou a deficiência na ingestão de folato pela maioria dos pacientes; enquanto que vitamina B12 e ferro estiveram de acordo com as RDA’s. Conclusão: A causa da anemia nestes pacientes talvez não tenha sido em função desta deficiente ingestão de folato, ainda mais por se tratar de um estudo descritivo. Ressalta-se a importância do profissional para o acompanhamento nutricional destes pacientes, para a promoção de um adequado estado nutricional e qualidade de vida. / Was develop a descritive study conducted in the Porto Alegre Clinics’ Hospital, from october 2001 to October 2002, with positive HIV and anemics patients. Objectives: Evaluate the association between anemia and nutritional status in positive HIV patients. Methodology: Were included 34 patients under 18 years old, all diagnosed with anemia. Laboratorial exams, evaluation of food intake (24h register), questionary of food intake frequence and anthropometrics data were collected. Results: The 24h register food intake showed the deficiency in folate intake by most of patients ,while vitamine B12 and iron intake were accorded RDA’s. Conclusions: The etiology of anemia in these patients maybe wasn´t cause by this folate deficiency, also because this was a describe study. The presence of a professional appears to be important for the nutritional treatment of these patients, to develop a health nutrional status and quality of life.